Private Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.1M | Buy |
142,915
+206
| +0.1% | +$45.7K | 2.39% | 14 |
|
|
2025
Q4 | $32.6M | Sell |
142,709
-6,413
| -4% | -$1.46M | 2.31% | 13 |
|
|
2025
Q3 | $34.5M | Sell |
149,122
-616
| -0.4% | -$125K | 2.46% | 9 |
|
|
2025
Q2 | $27.8M | Sell |
149,738
-5,969
| -4% | -$1.11M | 2.17% | 11 |
|
|
2025
Q1 | $32.6M | Sell |
155,707
-1,087
| -0.7% | -$211K | 2.7% | 9 |
|
|
2024
Q4 | $27.9M | Buy |
156,794
+10,505
| +7% | +$1.93M | 2.13% | 13 |
|
|
2024
Q3 | $28.9M | Sell |
146,289
-295
| -0.2% | -$55.1K | 2.3% | 12 |
|
|
2024
Q2 | $25.1M | Sell |
146,584
-2,065
| -1% | -$342K | 1.86% | 17 |
|
|
2024
Q1 | $27.1M | Sell |
148,649
-6,298
| -4% | -$1.09M | 2.16% | 15 |
|
|
2023
Q4 | $24M | Sell |
154,947
-2,440
| -2% | -$356K | 2.03% | 19 |
|
|
2023
Q3 | $23.5M | Sell |
157,387
-3,489
| -2% | -$512K | 2.24% | 15 |
|
|
2023
Q2 | $21.7M | Sell |
160,876
-901
| -0.6% | -$132K | 1.99% | 17 |
|
|
2023
Q1 | $25.8M | Buy |
161,777
+1,521
| +0.9% | +$233K | 2.57% | 11 |
|
|
2022
Q4 | $25.9M | Buy |
160,256
+6,519
| +4% | +$1,000K | 2.96% | 11 |
|
|
2022
Q3 | $20.6M | Buy |
153,737
+3,556
| +2% | +$510K | 2.64% | 12 |
|
|
2022
Q2 | $23M | Sell |
150,181
-11,107
| -7% | -$1.7M | 2.67% | 11 |
|
|
2022
Q1 | $26.1M | Sell |
161,288
-2,824
| -2% | -$410K | 2.34% | 13 |
|
|
2021
Q4 | $22.2M | Buy |
164,112
+36,119
| +28% | +$4.27M | 1.88% | 16 |
|
|
2021
Q3 | $13.8M | Buy |
127,993
+4,251
| +3% | +$486K | 1.28% | 27 |
|
|
2021
Q2 | $13.9M | Buy |
123,742
+316
| +0.3% | +$35.6K | 1.29% | 28 |
|
|
2021
Q1 | $13.4M | Buy |
123,426
+3,763
| +3% | +$403K | 1.41% | 25 |
|
|
2020
Q4 | $12.8M | Buy |
119,663
+17,517
| +17% | +$1.68M | 1.39% | 22 |
|
|
2020
Q3 | $8.95M | Buy |
102,146
+7,210
| +8% | +$679K | 1.05% | 27 |
|
|
2020
Q2 | $9.32M | Buy |
94,936
+45,140
| +91% | +$3.97M | 1.28% | 24 |
|
|
2020
Q1 | $3.79M | Sell |
49,796
-2,169
| -4% | -$185K | 0.64% | 33 |
|
|
2019
Q4 | $4.6M | Buy |
51,965
+48,815
| +1,550% | +$4.05M | 0.63% | 39 |
|
|
2019
Q3 | $239K | Sell |
3,150
-2,100
| -40% | -$144K | 0.04% | 109 |
|
|
2019
Q2 | $382K | Buy |
5,250
+500
| +11% | +$39.3K | 0.06% | 96 |
|
|
2019
Q1 | $383K | Sell |
4,750
-300
| -6% | -$24.5K | 0.06% | 93 |
|
|
2018
Q4 | $466K | Hold |
5,050
| – | – | 0.09% | 73 |
|
|
2018
Q3 | $478K | Hold |
5,050
| – | – | 0.07% | 90 |
|
|
2018
Q2 | $468K | Sell |
5,050
-2,400
| -32% | -$234K | 0.08% | 92 |
|
|
2018
Q1 | $705K | Hold |
7,450
| – | – | 0.12% | 84 |
|
|
2017
Q4 | $720K | Hold |
7,450
| – | – | 0.13% | 84 |
|
|
2017
Q3 | $662K | Sell |
7,450
-300
| -4% | -$22.8K | 0.13% | 84 |
|
|
2017
Q2 | $562K | Sell |
7,750
-200
| -3% | -$13.4K | 0.12% | 79 |
|
|
2017
Q1 | $518K | Sell |
7,950
-46,335
| -85% | -$2.91M | 0.11% | 79 |
|
|
2016
Q4 | $3.4M | Sell |
54,285
-54,800
| -50% | -$3.34M | 0.81% | 35 |
|
|
2016
Q3 | $6.88M | Sell |
109,085
-3,475
| -3% | -$225K | 1.65% | 21 |
|
|
2016
Q2 | $6.97M | Buy |
112,560
+10,110
| +10% | +$616K | 1.67% | 19 |
|
|
2016
Q1 | $5.85M | Sell |
102,450
-10,290
| -9% | -$574K | 1.41% | 24 |
|
|
2015
Q4 | $6.68M | Buy |
112,740
+42,030
| +59% | +$2.42M | 1.56% | 21 |
|
|
2015
Q3 | $3.85M | Buy |
70,710
+46,230
| +189% | +$3.01M | 0.97% | 35 |
|
|
2015
Q2 | $1.65M | Buy |
24,480
+900
| +4% | +$58.8K | 0.37% | 60 |
|
|
2015
Q1 | $1.38M | Hold |
23,580
| – | – | 0.32% | 68 |
|
|
2014
Q4 | $1.54M | Buy |
23,580
+500
| +2% | +$31.5K | 0.36% | 67 |
|
|
2014
Q3 | $1.33M | Buy |
23,080
+950
| +4% | +$52.7K | 0.29% | 82 |
|
|
2014
Q2 | $1.25M | Buy |
22,130
+500
| +2% | +$26.2K | 0.27% | 85 |
|
|
2014
Q1 | $1.11M | Sell |
21,630
-170
| -0.8% | -$8.59K | 0.26% | 84 |
|
|
2013
Q4 | $1.15M | Buy |
21,800
+1,200
| +6% | +$59K | 0.26% | 81 |
|
|
2013
Q3 | $921K | Hold |
20,600
| – | – | 0.22% | 91 |
|
|
2013
Q2 | $852K | Buy |
+20,600
| New | +$901K | 0.21% | 93 |
|
Other funds holding ABBV
VCM
VPM
Private Wealth Partners's ABBV Position: Q1 2026 in Review
Private Wealth Partners increased its AbbVie (ABBV) stake by 0.14% in Q1 2026, buying an estimated $45.7K and bringing the position to 142,915 shares worth $31.1M. The position accounts for 2.39% of the portfolio, ranked #14.
Private Wealth Partners first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.5M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Private Wealth Partners held 142,915 shares of AbbVie worth $31.1M as of Q1 2026.
- Private Wealth Partners bought 206 AbbVie shares in Q1 2026, an estimated $45.7K.
- AbbVie made up 2.39% of Private Wealth Partners's portfolio in Q1 2026, its #14 holding.
- Private Wealth Partners first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Private Wealth Partners's AbbVie position peaked at $34.5M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.